Healthcare Kiran Mazumdar Shaw of Biocon and oncologist Siddhartha Mukherjee bring CAR T-cell therapy to cancer patients in India; Find all the details here Updated : September 17, 2019 06:45 AM IST Chimeric Antigen Receptor (CAR) T-cell therapy is currently not available in India. In the US, two drugs approved for this therapy are sold for nearly Rs 3 crore per person. Working on reducing the price of this drug in India by tenfold. Subscribe to Moneycontrol PRO at just Rs.33/- per month for the first year. Use code SUPERPRO. Limited period offer. Available on Web and Android.